# Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

> **NCT02086526** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 68 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02086526
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-11-20
- **Final completion:** 2016-11-20
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2018-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02086526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02086526, "Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02086526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*